Aveo Capital Partners’s CVS Health CVS Stock Holding History

Aveo Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,760	Closed	-$251K	–	36
2025 Q1	$251K	Sell	3,760 -1,807	-32%	-$108K	0.04%	158
2024 Q4	$250K	Buy	+5,567	New	+$312K	0.03%	313
2023 Q1	–	Sell	-5,889	Closed	-$549K	–	347
2022 Q4	$549K	Buy	5,889 +427	+8%	+$41.2K	0.08%	177
2022 Q3	$521K	Buy	5,462 +2,801	+105%	+$277K	0.09%	163
2022 Q2	$247K	Sell	2,661 -82	-3%	-$8K	0.04%	240
2022 Q1	$278K	Sell	2,743 -115	-4%	-$12.1K	0.05%	222
2021 Q4	$295K	Buy	2,858 +374	+15%	+$34.6K	0.05%	225
2021 Q3	$211K	Buy	2,484 +45	+2%	+$3.77K	0.04%	238
2021 Q2	$204K	Buy	+2,439	New	+$200K	0.05%	252
2019 Q2	–	Sell	-2,582	Closed	-$139K	–	190
2019 Q1	$139K	Buy	+2,582	New	+$159K	0.06%	163
2018 Q1	–	Sell	-2,768	Closed	-$201K	–	146
2017 Q4	$201K	Buy	+2,768	New	+$201K	0.07%	135

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aveo Capital Partners's CVS Position: Q2 2025 in Review

Aveo Capital Partners sold out of CVS Health (CVS) in Q2 2025, closing a stake of 3,760 shares — an estimated $251K sold.

Aveo Capital Partners first reported a position in CVS in Q4 2017 and held it in 11 quarters. The position peaked at $549K in Q4 2022. 1,758 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

Aveo Capital Partners reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
Aveo Capital Partners sold 3,760 CVS Health shares in Q2 2025, an estimated $251K.
Aveo Capital Partners first reported a position in CVS Health in Q4 2017 and held it in 11 quarters.
Aveo Capital Partners's CVS Health position peaked at $549K in Q4 2022.
1,758 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Aveo Capital Partners's 13F filing for Q2 2025.